Robert L. Zerbe M.D., Director at Vericel Corp (VCEL), sold 2,500 shares at $62.50 ($156K) on 2025-02-05, disclosed to the SEC on 2025-02-07.
Scheduled sale ($156k) by Director under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Negative factors outweigh the positive ones.
| Filing → |
| VCEL | SELL | 2024-03-29 | $338K | — | Filing → |
| VCEL | SELL | 2024-02-22 | $36K | — | Filing → |
| VCEL | SELL | 2024-01-30 | $102K | — | Filing → |